Exelixis
EXEL
#1551
Rank
$14.62 B
Marketcap
$59.01
Share price
-0.20%
Change (1 day)
55.78%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company